To determine whether Helicobacter pylori infection affects clearance of a concomitant viral infection and cytotoxic T lymphocyte (CTL) and cytokine response to that infection, H. pylori -infected BALB/c mice were challenged with a recombinant vaccinia virus expressing human immunodeficiency virus type 1 gp160. Two H. pylori strains, a colonizing clinical isolate (KS612) and an established standard noncolonizing strain (NCTC11637), were compared. Clearance of recombinant vaccinia virus was reduced in KS612-infected mice compared with NCTC11637-infected and control mice. As a potential mechanism, in contrast to control or NCTC11637-infected mice, the H. pylori clinical isolate KS612 diminished gp160-specific and vaccinia virus -specific CTL activity, even in the presence of exogenous interleukin-2. Furthermore, KS612-infected mice had reduced Th1 cytokine responses to gp120 in vitro compared with control or NCTC11637-infected mice. These results have implications for possible effects of prevalent H. pylori infection on other human diseases.
Helicobacter pylori, a gram-negative spiral bacterium first tory reactions to mediate protection in vivo, since H. pylori is isolated in 1982 from a patient with chronic active gastritis an extracellular bacterium [7] . H. pylori infection of gastric [1] , is responsible for a large portion of chronic gastritis and mucosa is characterized by an increased secretion of the cytonearly all duodenal ulcers, most gastric ulcers, and probably kines tumor necrosis factor-a (TNF-a) and interleukin (IL)-6 an increased risk of gastric adenocarcinoma [2, 3] . More than and -8 [8, 9] . Also, H. pylori was found to stimulate peripheral 50% of the adult population is infected with H. pylori, in blood lymphocytes to proliferate and secrete cytokines interdeveloping as well as in developed countries [4] . H. pylori feron (IFN)-g and TNF-a in sensitized (i.e., antibody-positive) infection is also common (40% -55%) in human immunodefiand nonsensitized patients [10] . An overreaction of Th2 activaciency virus type 1 (HIV-1) -positive patients [5, 6] . Antibiotic tion might be responsible for the inadequacy of the immune therapy for gastroduodenal ulcers associated with H. pylori system to cure H. pylori infection. The finding of a low secreinfection was recently introduced and found to be effective.
tion of IFN-g in lymphocyte cultures with H. pylori in antiHowever, a prophylactic vaccine may prevent reinfection and body-positive patients is consistent with this hypothesis [10] . result in long-term eradication of the bacterium from the popuIt has been shown that heat-shock protein homologs of lation by herd immunity, in addition to being much more cost-H. pylori, HspA and Hsp B, elicit high levels of H. pylorieffective. Elucidation of the natural immunologic response durspecific IgG1 antibodies and confer immunity to gastric mucoing the pathogenesis of H. pylori infection is important for sal infections in mice previously immunized with H. pylori developing strategies of immunotherapy as well as vaccines antigens. This response is likely to be mediated by a predomiand for the treatment or prevention of ulcer formation and nantly Th2-type immune response, which favors a switch to carcinogenesis. the IgG1 isotype [11] . However, in other studies in mice, a Little is known of the function that T cells and cellular predominant Th1-like response was seen to Helicobacter felis immunity play in H. pylori -associated diseases. The primary infection, although IL-4 production was seen in immunized T cell response that might contribute to protection against and challenged mice [12]. Thus, the cytokine balance may H. pylori should be a CD4 / T cell response, which regulates depend on the specific system studied. antibody production by B cells as well as other local inflammaIn certain infectious diseases in mice and humans, the Th1 pattern of cytokines is associated with resistance to infection, whereas the Th2 pattern is associated with progression of infec-JID 1998;177 (January) H. pylori Alters Viral Clearance and CTL cells were heat-inactivated and sonicated on ice for 50 s three (CTL) activity and delayed clearance of virus [14, 26, 27] .
times at 20-s intervals with a sonifier (Branson Ultrasonics, DanGiven this interest in the interaction between disease organbury, CT) in the presence of glass beads. After removal of the isms, the precedent from S. mansoni infection that infection beads, the sonicate was centrifuged at 40,000 g for 1 h at 40ЊC. The with one organism might influence the immune response to supernatant was filtered and stored in aliquots at 020ЊC. Protein another pathogen, and the prevalence of H. pylori in HIVcontents were determined by the Lowry method.
infected persons [5] and the possibility that it might be a cofac- immobilized monoclonal antibody HB170 anti-IFN-g, a polypreviously shown to be free of Helicobacter organisms, were oroclonal rabbit anti-mouse IFN-g antibody, and peroxidase-conjugastrically administered three times at 2-day intervals an aliquot gated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboraof 10 9 cfu of a fresh clinical isolate of H. pylori (KS612), which tories, West Grove, PA) followed by ABTS substrate can colonize in the murine stomach and were reisolated from the (Kirkegaard & Perry, Gaithersburg, MD). The amount of cytokine colonized murine stomach, or an established standard control strain was quantitated by comparison to standard curves constructed with (NCTC11637), which is unable to colonize. At the time points recombinant IFN-g (Genentech, South San Francisco). studied, H. pylori colonization was assessed by the urease test, The differences remained qualitatively similar when normalized growth in culture, and morphology as described previously [38, for percentage of spleen cells that were CD4 / and CD8 / as deter-39]. Two weeks later, H. pylori-infected and uninfected control mined by flow cytometry. The difference in CD4 / and CD8 / mice were inoculated intravenously in the tail with 10 7 pfu of a spleen cells was not significant between each group as determined thymidine kinase-negative recombinant vaccinia virus, vPE16, by flow cytometry (data not shown). which expresses the HIV-1 gp160 [36, 37] . Persistent H. pylori CTL generation. Twenty days after vaccinia virus infection, infection was detectable in all mice used in the current study after immune spleen cells were inoculated into 24-well culture plates the inoculum of KS612 but in none of the mice after the inoculum (5 1 10 6 /mL) in complete T cell medium (1:1 mixture of RPMI of NCTC11637.
1640 and Eagle-Hanks amino acid medium containing 10% fetal Peptide synthesis. Peptides were synthesized on an automated calf serum, 2 mM L-glutamine, 100 U of penicillin/mL, 100 mg of peptide synthesizer (model 430A; Applied Biosystems, Foster City, streptomycin/mL, and 5 1 10 05 M 2-mercaptoethanol). Next, cells CA) by use of t-boc chemistry [40] . The peptides were cleaved were restimulated for 6 days in vitro with either 2 1 10 5 gp160 from the resin with HF and initially purified by size exclusion gene-transfected H-2 d fibroblasts (15-12 cells)/mL, mitomycin Cchromatography. Purification to single peaks was achieved by retreated (100 mg/mL) for 30 min at 37ЊC, or 2. Mice infected with vPE16 alone generated strong CTL activity showed H. pylori colonization in their stomach, while no against gp160 and P18 (figure 1). Specific lysis was substantial H. pylori colonization was detected in the control mice inocuat effector-to-target ratios as low as 3:1 in those mice. However, lated with an established standard control strain (NCTC11637) mice infected with H. pylori KS612 prior to the gp160-expressor saline alone (data not shown). To assess the effect of ing vaccinia virus infection failed to generate comparably high H. pylori infection on immune responses to a virus, BALB/c CTL activity against the gp160-expressing transfectant, 15-12 mice infected with H. pylori were inoculated intravenously ( figure 1A ), or P18 ( figure 1B ) at all effector-to-target ratios with vPE16, a recombinant vaccinia virus expressing the tested, whereas the mice infected with control strain H. pylori HIV-1 gp160 envelope protein. The virus was given 2 weeks NCTC11637 prior to vaccinia virus infection mounted strong after the H. pylori infection. To assess whether the H. pylori CTL responses to the gp160 or P18 superimposable on those infection might affect the clearance of recombinant vaccinia of the mice infected with vPE16 alone. These CTL responses virus in vivo in vaccinia virus -infected H-2 d mice, we meawere specific for P18, a CTL immunodominant epitope of sured the clearance of vaccinia virus from different tissues at gp160, and failed to lyse BALB/c 3T3 fibroblast targets that various times after infection in control or H. pylori -infected express none of the HIV-1 envelope (gp120 or gp160) antigen mice. Three H-2 d mice per group were sacrificed at days 3, 7, (data not shown). Since 15-12 expresses major histocompatibil-14, and 28 after vaccinia virus infection, and virus titers in the ity complex class I molecules but not class II, CTL must recogliver and spleen were measured (table 1). At the time points nize the epitope in the context of class I molecules. Mice examined, no virus was detected in the livers, and the virus infected with H. pylori alone failed to mount CTL activity was detected in the spleen of mice infected with vaccinia virus against gp160. Thus, colonization of H. pylori KS612 resulted alone (i.e., control mice not infected with H. pylori) only at in reduced CTL generation against gp160 (3-to 9-fold in lytic day 3. Infection with the noncolonizing control strain of units), whereas the noncolonizing strain, NCTC11637, failed to diminish the CTL response. This modest reduction in lytic H. pylori NCTC11637 did not affect this outcome. However, 
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10-30-97 17:50:50 jinfa UC: J Infect units is sufficient to almost completely eliminate killing at low effector-to-target ratios that may reflect the situation in vivo (e.g., at 3.7:1 in figure 1A) . To examine the effect on vaccinia virus -specific CTL, the splenic cells from mice infected with vaccinia virus alone, vaccinia virus and H. pylori (KS612 or NCTC11637), or KS612 alone, after restimulation with control vaccinia virus vSC8-infected 3T3 fibroblasts and IL-2 (at exogenous IL-2 levels during CTL generation in vitro sufficient to compensate for deficiency in T cell help in vitro), were tested for CTL activity against epitopes of the vaccinia virus itself. The vaccinia virusspecific CTL activity was also reduced (3-to 9-fold in lytic units) in the mice doubly infected with vaccinia virus plus KS612 compared with mice infected with vaccinia virus alone or vaccinia virus plus NCTC11637 ( figure 1C) . No CTL activity against vaccinia virus was detected in mice infected with KS612 or NCTC11637 alone (data not shown). These specific CTL were found to be CD8
0 (data not shown). The differences seen in figure 1 remained qualitatively similar when normalized for percentage of spleen cells that were CD8
/ as determined by flow cytometry. There was no significant difference in CD8
/ spleen cell numbers between groups as determined by flow cytometry (data not shown).
The mechanism of inhibition of CTL induction by colonizing H. pylori infection is not clear but might be related to a shift in cytokine production from Th1-like to Th2-like, given the similar experience in schistosomiasis [14] and the known effect of H. pylori on in vitro cytokine production by lymphocytes from infected patients [10] . Therefore, we tested whether cytokine production to HIV-1 envelope protein was affected by H. pylori infection in gp160 -vaccinia virus doubly infected mice. Twenty days after viral infection, we found that the Th1 cytokine (IFN-g and IL-2) responses to the gp120 antigen expressed by the recombinant vaccinia virus were down-regulated in all mice inoculated with the colonizing strain KS612 and vaccinia virus ( figure 2A and 2B ). Splenic cells from the mice infected with vaccinia virus alone or mice inoculated with vaccinia virus and the noncolonizing strain NCTC11637 produced high levels of IFN-g and IL-2 in response to in vitro stimulation with recombinant gp120 but lower IL-4 levels to H. pylori antigens (figure 2). Figure 2 also shows no detectable H. pylori -specific cytokine production in the mice infected with vaccinia virus alone and in those infected with vaccinia virus and noncolonizing NCTC11637. Conversely, spleen cells 
CD4
/ T cells, in experiments in which CD4 / or CD8 / T cells were selectively deleted by treatment with monoclonal antibodies and complement ( figure 3 ). The differences seen in figure 2 remained qualitatively similar when normalized for percentage of spleen cells that were CD4 / as determined by flow cytometry. There was no significant difference in CD4 / spleen cells between each group as determined by flow cytometry (data not shown).
Discussion

CD4
/ T cell responses to viral antigens are important in controlling infection by providing help for B cell humoral and CD8 / T cell responses protective against the disease, as well as producing protective cytokines themselves. It was suggested that a strong T cell response to HIV proteins is associated with a favorable course of the infection [22, 48 -68] . CTL may contribute to elimination of virus. We have found that impaired anti-gp160 or anti -vaccinia virus CTL responses are associated with delayed or diminished clearance of virus or virus-infected cells [14, 69] .
Over the last decade, Th1-type CD4 / cells producing IL-2 and IFN-g and Th2-type CD4
/ cells producing IL-4 and IL-5 have been identified in mice and humans [13, 70 -72] . In certain chronic infectious parasitic, bacterial, and viral diseases, the Th1 pattern of cytokines is associated with resistance to infection, whereas the Th2 pattern is associated with progressive forms of infection, with a few exceptions in some parasitic infections [13 -23] . A switch from the Th1 to the Th2 cytokine phenotype has been found to occur during the course of HIV infection [63] . In the case of Helicobacter species, different results have been reported for the predominant cytokine response to Helicobacter antigens in mice, depending on the system used [11, 12] . However, cytokine production specific for non -H. pylori antigens has not been examined in these mice. Nevertheless, it was this analogy between H. pylori infection and other chronic parasitic and bacterial infections that led us to ask whether H. pylori infection, like S. mansoni infection [14, 26] , would influence the immune response to other unrelated antigens and, in particular, concomitant viral infections. The results indicate that experimental H. pylori infection indeed induces a decrease in the ability of mice to clear even an attenuated thymidine kinase -negative recombinant vaccinia virus.
We hypothesized that this reduced viral clearance is the result of down-regulation in virus-specific Th1 cytokine and HIV-1 -positive persons without AIDS (53%) [5] . However, a 511-3. subsequent study that used histology found a prevalence of 
